BlackRock Investment Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$1.45M	Sell	27,253 -299	-1%	-$17K	﹤0.01%	2444
2016 Q3	$1.67M	Sell	27,552 -196	-0.7%	-$12.2K	﹤0.01%	2301
2016 Q2	$1.83M	Buy	27,748 +4,739	+21%	+$301K	﹤0.01%	2177
2016 Q1	$1.3M	Buy	23,009 +801	+4%	+$90.1K	﹤0.01%	2305
2015 Q4	$5.22M	Buy	22,208 +96	+0.4%	+$20.9K	0.01%	1365
2015 Q3	$3.5M	Sell	22,112 -1,225	-5%	-$347K	﹤0.01%	1636
2015 Q2	$8.83M	Buy	23,337 +3,669	+19%	+$1.46M	0.01%	1081
2015 Q1	$8.22M	Buy	19,668 +1,825	+10%	+$653K	0.01%	1063
2014 Q4	$4.88M	Sell	17,843 -184	-1%	-$45.7K	0.01%	1374
2014 Q3	$3.5M	Buy	18,027 +68	+0.4%	+$14.8K	﹤0.01%	1600
2014 Q2	$4.4M	Buy	17,959 +1,296	+8%	+$293K	0.01%	1489
2014 Q1	$4.42M	Buy	16,663 +117	+0.7%	+$44.8K	0.01%	1458
2013 Q4	$6.01M	Buy	16,546 +1,135	+7%	+$437K	0.01%	1224
2013 Q3	$8.19M	Buy	15,411 +816	+6%	+$280K	0.01%	966
2013 Q2	$3.42M	Buy	+14,595	New	+$2.87M	0.01%	1471